Theraclion SA

[ Editor's note: Complete historical data on global device approvals can be found in Medtech Insight 's Approvals Tracker and at MedDeviceTracker.] The US FDA approved one original PMA between 9 Ap

Seven novel device or indication approvals were added to Medtech Insight 's Approvals Tracker last week, including actions in the US, Europe and Taiwan. Among approvals in Europe, HeartStitch, Inc.

Theraclion SAS is shifting some of its focus from treating benign breast fibroadenomas to treating metastatic breast cancer with the start of a new clinical trial of its non-invasive Echopulse hig

A couple of joint ventures were throw in the deal mix for March and April, including one that would give a French company entry into the lucrative China market. Theraclion SAS , based in Malakoff,